Understanding Dry Eye Syndrome

The tear film consists of three layers: an outer oily layer from meibomian glands to prevent evaporation, a middle watery layer for moisture from lacrimal glands, and an inner mucus layer to help tears adhere to the eye surface. Proteins and antibodies in tears also protect against infections, and any disruption can lead to dry eye symptoms that our team addresses with targeted therapies.

Various factors can destabilize your tear film, often combining to worsen the condition over time. Our ophthalmologists at ReFocus Eye Health Danbury identify these during comprehensive exams to tailor treatments for lasting relief.

• Aging, which decreases tear production, particularly after age 50.
• Hormonal shifts from menopause, pregnancy, birth control, or hormone therapy.
• Environmental triggers such as dry air, wind, smoke, air conditioning, or high altitudes.
• Autoimmune or systemic conditions like Sjögren's syndrome, rheumatoid arthritis, lupus, thyroid disorders, or diabetes.
• Medications including antihistamines, antidepressants, blood pressure drugs, diuretics, or acne treatments.
• Eye-related issues like contact lens overwear, allergies, or prior surgeries such as LASIK or cataract procedures.

Dry eye falls into main categories that frequently overlap, guiding our ophthalmologists in selecting the best approach for you. Understanding your type ensures more precise management at ReFocus Eye Health Danbury.

• Evaporative dry eye, caused by insufficient oil from blocked meibomian glands, leading to quick tear loss.
• Aqueous-deficient dry eye, from reduced watery tear production by lacrimal glands.
• Mixed dry eye, combining both types, which is the most prevalent and often requires combined treatments.

An irregular tear film blurs vision by creating an uneven eye surface, often clearing briefly with blinks as tears redistribute. Chronic inflammation from untreated dry eye can harm the cornea over time, but our advanced interventions at ReFocus Eye Health Danbury help prevent such complications and maintain clear sight.

We begin with a thorough symptom and history review, followed by non-invasive tests to evaluate your tears and ocular surface. These insights allow us to pinpoint causes and track progress accurately.

• Schirmer's test with paper strips measures tear volume over five minutes.
• Tear breakup time assesses evaporation speed using fluorescein dye.
• Osmolarity evaluates salt levels in tears for instability indicators.
• Meibography images eyelid glands to detect blockages or atrophy.

Artificial tears serve as initial relief for mild cases, with preservative-free versions ideal for frequent use to avoid added irritation. Gel drops offer extended lubrication despite brief blurring, and daily 10-minute warm compresses effectively unblock glands for better tear quality.

For persistent inflammation, prescriptions stimulate natural tear production and reduce swelling, often showing benefits in weeks to months. Options include cyclosporine-based drops like Restasis, Cequa, Vevye, or Xiidra, and newer Miebo for evaporative types targeting meibomian function.

Severe cases respond well to our in-office therapies that address root issues directly. These minimally invasive options provide quick, durable improvements under expert supervision.

• Punctal plugs block tear ducts to retain natural moisture longer.
• LipiFlow or iLux applies heat and pressure to melt gland blockages.
• Intense pulsed light therapy eases inflammation and enhances gland output.
• Radiofrequency treatments stimulate collagen and improve circulation.
• Autologous serum drops from your blood supply healing growth factors.